OPKO Health Statistics
Total Valuation
OPKO Health has a market cap or net worth of GBP 820.06 million. The enterprise value is 914.85 million.
Market Cap | 820.06M |
Enterprise Value | 914.85M |
Important Dates
The next estimated earnings date is Friday, October 31, 2025.
Earnings Date | Oct 31, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 793.78M |
Shares Outstanding | n/a |
Shares Change (YoY) | -4.63% |
Shares Change (QoQ) | +17.34% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 376.55M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1.69 |
PB Ratio | 0.87 |
P/TBV Ratio | 18.20 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -7.08 |
EV / Sales | 1.87 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -4.83 |
Financial Position
The company has a current ratio of 3.41, with a Debt / Equity ratio of 0.31.
Current Ratio | 3.41 |
Quick Ratio | 2.21 |
Debt / Equity | 0.31 |
Debt / EBITDA | n/a |
Debt / FCF | -1.53 |
Interest Coverage | -2.28 |
Financial Efficiency
Return on equity (ROE) is -13.16% and return on invested capital (ROIC) is -9.96%.
Return on Equity (ROE) | -13.16% |
Return on Assets (ROA) | -8.46% |
Return on Invested Capital (ROIC) | -9.96% |
Return on Capital Employed (ROCE) | -14.85% |
Revenue Per Employee | 161,720 |
Profits Per Employee | -43,141 |
Employee Count | 2,997 |
Asset Turnover | 0.34 |
Inventory Turnover | 8.97 |
Taxes
In the past 12 months, OPKO Health has paid 17.97 million in taxes.
Income Tax | 17.97M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -9.02% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -9.02% |
50-Day Moving Average | 1.36 |
200-Day Moving Average | 1.48 |
Relative Strength Index (RSI) | 55.09 |
Average Volume (20 Days) | 8,200 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 11.61 |
Income Statement
In the last 12 months, OPKO Health had revenue of GBP 484.67 million and -129.29 million in losses. Loss per share was -0.19.
Revenue | 484.67M |
Gross Profit | 70.39M |
Operating Income | -195.29M |
Pretax Income | -111.32M |
Net Income | -129.29M |
EBITDA | -126.16M |
EBIT | -195.29M |
Loss Per Share | -0.19 |
Balance Sheet
The company has 195.09 million in cash and 288.85 million in debt, giving a net cash position of -93.76 million.
Cash & Cash Equivalents | 195.09M |
Total Debt | 288.85M |
Net Cash | -93.76M |
Net Cash Per Share | n/a |
Equity (Book Value) | 946.61M |
Book Value Per Share | 1.21 |
Working Capital | 300.83M |
Cash Flow
In the last 12 months, operating cash flow was -174.78 million and capital expenditures -14.47 million, giving a free cash flow of -189.26 million.
Operating Cash Flow | -174.78M |
Capital Expenditures | -14.47M |
Free Cash Flow | -189.26M |
FCF Per Share | n/a |
Margins
Gross margin is 14.52%, with operating and profit margins of -40.29% and -26.68%.
Gross Margin | 14.52% |
Operating Margin | -40.29% |
Pretax Margin | -22.97% |
Profit Margin | -26.68% |
EBITDA Margin | -26.03% |
EBIT Margin | -40.29% |
FCF Margin | n/a |
Dividends & Yields
OPKO Health does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 4.63% |
Shareholder Yield | 4.63% |
Earnings Yield | -15.77% |
FCF Yield | -23.08% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
OPKO Health has an Altman Z-Score of -0.55 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -0.55 |
Piotroski F-Score | 2 |